Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $77.38 USD
Change Today +0.77 / 1.01%
Volume 4.5M
MDT On Other Exchanges
New York
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher James O'Connell

Executive Vice President and Group President of Restorative Therapies Group, Medtronic plc
AgeTotal Calculated CompensationThis person is connected to 45 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Christopher James O'Connell, also known as Chris, has been an Executive Vice President and Group President of Restorative Therapies Group at Medtronic plc since August 2009. Mr. O'Connell has global responsibility for Medtronic’s Spine and Biologics, Neuromodulation, Surgical Technologies and Orthopedics business units. Mr. O'Connell provides overall strategic direction and global operational oversight for this group of related businesses, as well as leading the ...

Read Full Background

Corporate Headquarters*

20 Lower Hatch Street
Dublin, Co. Dublin 2


Phone: 353 1 438 1700
Fax: --

Board Members Memberships*

Former Non-Executive Director


MBA 1994
Harvard University
Bachelor's Degree 1989
Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$675,135

Stock Options*

Restricted Stock Awards$833,009
All Other Compensation$35,340
Exercised Options32,411
Exercised Options Value$229,834
Exercisable Options299,206
Exercisable Options Value$5,192,615
Unexercisable Options180,298
Unexercisable Options Value$2,656,066
Total Value of Options$8,078,515
Total Number of Options511,915

Total Compensation*

Total Annual Cash Compensation$1,973,268
Total Short Term Compensation$675,135
Other Long Term Compensation$868,349
Total Calculated Compensation$3,785,854
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $77.38 USD +0.77


Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Strategy Committee and Chairman of Appointments & Governance Committee
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at